AccueilSTAR • NSE
add
Strides Arcolab
Dernière clôture
1 388,85 ₹
Variation sur la journée
1 370,00 ₹ - 1 434,00 ₹
Plage sur l'année
472,30 ₹ - 1 675,00 ₹
Capitalisation boursière
130,15 Md INR
Volume moyen
338,40 k
Ratio cours/bénéfices
56,35
Rendement (dividendes)
0,18 %
Place boursière principale
NSE
Actualités des marchés
Données financières
Compte de résultat
Chiffre d'affaires
Résultat net
(INR) | sept. 2024info | Variation Y/Y |
---|---|---|
Chiffre d'affaires | 12,01 Md | 20,18 % |
Charges d'exploitation | 5,18 Md | 6,06 % |
Résultat net | 932,32 M | 170,98 % |
Marge bénéficiaire nette | 7,76 | 159,06 % |
Bénéfice par action | — | — |
EBITDA | 2,35 Md | 53,62 % |
Taux d'imposition effectif | 18,46 % | — |
Bilan
Total des actifs
Total du passif
(INR) | sept. 2024info | Variation Y/Y |
---|---|---|
Trésorerie/Invest. court terme | 2,47 Md | -24,31 % |
Total des actifs | 59,90 Md | -5,49 % |
Total du passif | 37,75 Md | -13,11 % |
Total des capitaux propres | 22,15 Md | — |
Actions en circulation | 91,94 M | — |
Ratio cours/valeur comptable | 5,62 | — |
Rentabilité des actifs | — | — |
Retour sur capitaux | 10,17 % | — |
Flux de trésorerie
Variation nette en trésorerie
(INR) | sept. 2024info | Variation Y/Y |
---|---|---|
Résultat net | 932,32 M | 170,98 % |
Trésorerie (opérations) | — | — |
Trésorerie (invest.) | — | — |
Trésorerie (financement) | — | — |
Variation nette en trésorerie | — | — |
Flux de trésorerie dispo. | — | — |
À propos
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
Date de fondation
1990
Siège social
Site Web
Employés
3 065